Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
22:42
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

WFH 2014 World Congress

 

11-15 May 2014 Melbourne
FAQs
   
Discussion forum - WFH 2014 World Congress
    Topic - Clinical Issues and Trials

If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER.
 

Poster: 44
Visits: 146
Title: Latest Results From The PUP-GCP Clinical Trial: A Low Inhibitor Rate In Previously Untreated Patients With Severe Hemophilia A Treated With Octanate
Authors: Anna Klukowska , Anna Klukowska, Sigurd Knaub, Vladimir Komrska, Pawel Laguna, Vladimir Vdovin, Martina Jansen
Centre: Octapharma Clinical R&D

You must be registered to reply or comment.

LATEST RESULTS FROM THE PUP-GCP CLINICAL TRIAL: A LOW INHIBITOR RATE IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A TREATED WITH OCTANATE

Anna Klukowska
Thread initiator
Subspeciality
Reg: 5/5/2014 5:45:00 PM

Comment# 1

I invite healthcare professionals to open debate around the issues raised in my poster, both those relating to research and to clinical practice.

Comment added on 5/5/2014 5:45:00 PM 
     
You must be registered to reply or comment.



Most viewed poster for this congress
Poster: 1
Visits: 2526
Title: A WEB SITE TO IMPROVE MANAGEMENT OF PATIENTS WITH INHERITED BLEEDING DISORDERS IN THE EMERGENCY DEPARTMENT: RESULTS AT 2 YEARS
Authors: Annarita Tagliaferri ,
Centre: Centro di Riferimento Regionale per la cura dellEmofilia

Poster most viewed in this topic
Poster: 43
Visits: 280
Title: A Clinical Study In Previously Untreated Patients With Severe Haemophilia A - Immunogenicity, Efficacy and Safety Of Treatment With Human-cl rhFVIII
Authors: Raina Liesner , M Jansen, S Knaub
Centre: Octapharma Clinical R&D


 








PosterSessionOnline
Logo Draft
 
Logo Cert